No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GHRS GH Research
- 11.950
- +0.900+8.14%
Close Jul 22 16:00 ET
- 11.520
- -0.430-3.60%
Post 16:04 ET
621.74MMarket Cap-19274P/E (TTM)
12.150High10.720Low58.18KVolume11.200Open11.050Pre Close654.32KTurnover0.78%Turnover RatioLossP/E (Static)52.03MShares14.99052wk High2.96P/B89.51MFloat Cap5.05052wk Low--Dividend TTM7.49MShs Float30.430Historical High--Div YieldTTM12.94%Amplitude5.050Historical Low11.247Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew rec
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersENDRA Life Sciences (NASDAQ:NDRA) stock increased by 79.2% to $0.15 during Wednesday's regular session. The company's market cap stands at $1.6 million. Rezolute (NASDAQ:RZLT) stock moved upwar
Psychedelic Stocks Fall as FDA Panel Rejects MDMA Therapy
FDA Advisory Panel Fails to Endorse Psychedelic MDMA Therapy for PTSD
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
Comments
$GH Research(GHRS.US$ Given the prospects for the European economy, a 20% downside should be reasonable.
Upgrades
• $ACADIA Pharmaceuticals(ACAD.US$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $22)
• $Arthur J. Gallagher(AJG.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182)
• $Apple Hospitality REIT Inc(APLE.US$ : B.Riley Upgrades to Buy from Neutral - PT $19
• $AutoZone(AZO.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125)
• $Boeing(BA.US$ : Citigroup Upgr...
• $ACADIA Pharmaceuticals(ACAD.US$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $22)
• $Arthur J. Gallagher(AJG.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182)
• $Apple Hospitality REIT Inc(APLE.US$ : B.Riley Upgrades to Buy from Neutral - PT $19
• $AutoZone(AZO.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125)
• $Boeing(BA.US$ : Citigroup Upgr...
8
$Full Truck Alliance(YMM.US$ $First Advantage(FA.US$ $Sprinklr(CXM.US$ $Bright Health Group(BHG.US$ $Confluent(CFLT.US$ $Doximity(DOCS.US$ $Miromatrix Medical Inc.(MIRO.US$ $Monte Rosa Therapeutics(GLUE.US$ $Soul(SSR.US$ $Acurx Pharmaceuticals(ACXP.US$ $Alpha Teknova(TKNO.US$ $Elevation Oncology(ELEV.US$ $GH Research(GHRS.US$ $Mister Car Wash(MCW.US$
Expand 47
11
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg